Zone de Texte: GMP are always strictly followed-up in France- by the Commission du Génie Biomoléculaire experiment authorisations -by the DRAF/SRPV for the follow-up of CGB requirements in authorised trials. Zone de Texte: Potential adverse effects of GMP are followed-up under the comité de Biovigilance authority. This control is realised by the DRAF/SRPV, under scientific expertise of INRA.

Previous
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26 
Next